+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Gilead Sciences Inc - logo

Founded in 1987 Gilead Sciences is a biopharmaceutical company focused on developing innovative treatments for life threatening illnesses. Their areas of research include HIV/AIDs, Liver Diseases, Hematology, Oncology, Cardiovascular and Respiratory disease. Gilead Sciences is based in California, USA and their product portfolio consists of well-known treatments like Atripla, Sovaldi, Zydelig, Viread and many more.

Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2024 - Product Thumbnail Image

Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems - Product Thumbnail Image

Nanoparticles in Biotechnology, Drug Development and Drug Delivery Systems

  • Report
  • June 2023
  • 174 Pages
  • Global
From
Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications, Type of Molecule, Type of Biologics, Route of Administration, Type of Therapy, Key Geographical Regions, Leading Drug Developers and Sales Forecast - Product Thumbnail Image

Rare Kidney Diseases Market: Industry Trends and Global Forecasts, Till 2035: Distribution by Target Disease Indications, Type of Molecule, Type of Biologics, Route of Administration, Type of Therapy, Key Geographical Regions, Leading Drug Developers and Sales Forecast

  • Report
  • May 2024
  • 240 Pages
  • Global
From
Hepatitis C Treatment - Global Strategic Business Report - Product Thumbnail Image

Hepatitis C Treatment - Global Strategic Business Report

  • Report
  • December 2024
  • 208 Pages
  • Global
From
Co-Promotion and Co-Marketing in Pharmaceuticals and Biotechnology 2014-2024 - Product Thumbnail Image

Co-Promotion and Co-Marketing in Pharmaceuticals and Biotechnology 2014-2024

  • Report
  • September 2024
  • 250 Pages
  • Global
From
COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global Forecast to 2025 - Product Thumbnail Image

COVID-19 Diagnostics (PCR Testing, Antibody Testing) and Therapy (Immunotherapy, Vaccines, Antiviral, Cell-based, Plasma therapy) Market Opportunity Assessment and Global Forecast to 2025

  • Report
  • July 2020
  • 100 Pages
  • Global
From
Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030 - Product Thumbnail Image

Fc Protein and Glyco-engineered Antibodies Market: Focus on Type of Fc Engineering and Therapeutics (3rd edition), 2021-2030

  • Report
  • July 2021
  • 290 Pages
  • Global
From
Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics: Distribution by Type of Protein degrader, Therapeutic Areas, Route of administration, Key Contributing Technologies and Key Geographies, 2021-2030 - Product Thumbnail Image

Targeted Protein Degradation Market: Focus on Technology Platforms and Therapeutics: Distribution by Type of Protein degrader, Therapeutic Areas, Route of administration, Key Contributing Technologies and Key Geographies, 2021-2030

  • Report
  • March 2021
  • 330 Pages
  • Global
From
Human Microbiome Market: Focus on Therapeutics, Diagnostics and Fecal Microbiota Therapy: Distribution by Type of Molecule, Type of Product, Target Indication, Therapeutic Areas, Supply Channels and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035 - Product Thumbnail Image

Human Microbiome Market: Focus on Therapeutics, Diagnostics and Fecal Microbiota Therapy: Distribution by Type of Molecule, Type of Product, Target Indication, Therapeutic Areas, Supply Channels and Key Geographical Regions: Industry Trends and Global Forecasts, 2022-2035

  • Report
  • April 2022
  • 552 Pages
  • Global
From
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 83 Pages
  • Global
From
Prefilled Syringes Market, Industry Trends and Global Forecasts, till 2035: Distribution by Purpose of Syringe, Therapeutic Area, Type of Molecule, Type of Needle System, Usability of Syringe, Type of Syringe, Type of Packaging and Key Geographical Regions - Product Thumbnail Image

Prefilled Syringes Market, Industry Trends and Global Forecasts, till 2035: Distribution by Purpose of Syringe, Therapeutic Area, Type of Molecule, Type of Needle System, Usability of Syringe, Type of Syringe, Type of Packaging and Key Geographical Regions

  • Report
  • February 2024
  • 867 Pages
  • Global
From
HIV Drugs - Global Strategic Business Report - Product Thumbnail Image

HIV Drugs - Global Strategic Business Report

  • Report
  • December 2024
  • 164 Pages
  • Global
From
Wearable Injectors Market (7th Edition): Distribution by Type of Device (Patch Pump / On Body Injector and Wearable Infusion Pump), Usability, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035 - Product Thumbnail Image

Wearable Injectors Market (7th Edition): Distribution by Type of Device (Patch Pump / On Body Injector and Wearable Infusion Pump), Usability, Therapeutic Area and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Report
  • August 2023
  • 664 Pages
  • Global
From
US Pharmaceutical Market Size and Forecast (2020 - 2030), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Vaccines, Biologics & Biosimilars, and Small Molecules) - Product Thumbnail Image

US Pharmaceutical Market Size and Forecast (2020 - 2030), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Vaccines, Biologics & Biosimilars, and Small Molecules)

  • Report
  • January 2024
  • 292 Pages
  • United States
From
Monoclonal Antibodies for Oncology: Global Markets - Product Thumbnail Image

Monoclonal Antibodies for Oncology: Global Markets

  • Report
  • June 2022
  • 124 Pages
  • Global
From
Biosimilars and Follow-On Biologics Market Report 2024-2034 - Product Thumbnail Image

Biosimilars and Follow-On Biologics Market Report 2024-2034

  • Report
  • May 2024
  • 391 Pages
  • Global
From
Liver Diseases Treatment - Global Strategic Business Report - Product Thumbnail Image

Liver Diseases Treatment - Global Strategic Business Report

  • Report
  • December 2024
  • 194 Pages
  • Global
From
Non-alcoholic Steatohepatitis (NASH) - Global Strategic Business Report - Product Thumbnail Image

Non-alcoholic Steatohepatitis (NASH) - Global Strategic Business Report

  • Report
  • December 2024
  • 179 Pages
  • Global
From
Antibody Discovery Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Antibody Discovery Method, Type of Antibody Generated, Nature of Antibody Generated, Type of Therapeutic Areas and Key Geographies - Product Thumbnail Image

Antibody Discovery Market Industry Trends and Global Forecasts to 2035, by Type of Service Offered, Antibody Discovery Method, Type of Antibody Generated, Nature of Antibody Generated, Type of Therapeutic Areas and Key Geographies

  • Report
  • November 2024
  • 525 Pages
  • Global
From
U.S. Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing: Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030 - Product Thumbnail Image

U.S. Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing: Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030

  • Report
  • September 2024
  • 116 Pages
  • United States
From
Loading Indicator